The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lazarus Alon since 2020.
This trader's CIK number is 1808244.
At the time of last reporting, Lazarus Alon was the Director of Werewolf Therapeutics, Inc.. (stock ticker symbol HOWL).
Also see all insider trading activities at Werewolf Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2021 | HOWL | 400,000 | $6,400,000 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2020 | KROS | 120,000 | $1,920,000 | 0 | $0 | 0 | $0 |
1. Werewolf Therapeutics, Inc. (HOWL)
2. Keros Therapeutics, Inc. (KROS)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-05-04 | HOWL | Buy | 400,000 | 16.00 | 6,400,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-04-13 | KROS | Buy | 120,000 | 16.00 | 1,920,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lazarus Alon (Director of Werewolf Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.